The possibility of psychiatric side effects may be to blame for the demise of two diet drugs. French drugmaker Sanofi-Aventis said it’s stopping all research on Accomplia - a diet drug sold in Europe. Just a few hours later, Pfizer Inc. announced it’s ending research on an experimental weight-loss drug in the same class.
Two weeks [...]



